CRBP logo

CRBP
Corbus Pharmaceuticals Holdings Inc

21,465
Mkt Cap
$194.31M
Volume
296,058.00
52W High
$20.56
52W Low
$4.64
PE Ratio
-2.01
CRBP Fundamentals
Price
$11.07
Prev Close
$11.07
Open
$10.98
50D MA
$13.36
Beta
1.51
Avg. Volume
494,978.65
EPS (Annual)
-$3.68
P/B
1.51
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Research Analysts Issue Forecasts for CRBP Q1 Earnings
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP - Free Report) - Analysts at HC Wainwright issued their Q1 2026 earnings estimates for Corbus Pharmaceuticals in a research note issued to investors...
MarketBeat·22h ago
News Placeholder
More News
News Placeholder
Royal Bank Of Canada Lowers Corbus Pharmaceuticals (NASDAQ:CRBP) Price Target to $53.00
Royal Bank Of Canada reduced their target price on shares of Corbus Pharmaceuticals from $55.00 to $53.00 and set an "outperform" rating on the stock in a research report on Thursday...
MarketBeat·2d ago
News Placeholder
Corbus Pharmaceuticals (NASDAQ:CRBP) Announces Earnings Results, Misses Expectations By $0.10 EPS
Corbus Pharmaceuticals (NASDAQ:CRBP - Get Free Report) announced its quarterly earnings results on Wednesday. The biopharmaceutical company reported ($1.90) EPS for the quarter, missing the consensus...
MarketBeat·3d ago
News Placeholder
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Given Average Rating of "Moderate Buy" by Brokerages
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP - Get Free Report) has earned an average rating of "Moderate Buy" from the eleven brokerages that are covering the stock, MarketBeat Ratings...
MarketBeat·7d ago
News Placeholder
Can Cannabis Stocks Reverse Their Prolonged Downtrend?
Cannabis stocks like TLRY and GTBIF remain deep in years-long slump, but U.S. federal reform or global expansion could ignite a long-awaited rebound.
Zacks·3mo ago
News Placeholder
Is Small-Cap Corbus Pharma a Worthy Cannabis Investment?
Zacks·6mo ago
News Placeholder
Corbus Announces Dosing of First Patient in U.S. Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC
Study enrolling patients with metastatic urothelial cancer (mUC) and other Nectin-4 enriched tumorsEmerging clinical profile from CSPC's Phase 1 China study indicates differentiation from PADCEV...
Globe Newswire·2y ago
News Placeholder
Corbus Pharmaceuticals Holdings (CRBP, $37.79) entered Downtrend as Momentum indicator drops below 0 level on Mar 21, 2024
This indicator may be signaling that CRBP's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...
Tickeron - Stocks·2y ago
News Placeholder
Corbus Pharmaceuticals Holdings (CRBP, $38.81) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 20, 2024
This is a Bearish indicator signaling CRBP's price could decline from here. Traders may explore shorting the stock or put options...
Tickeron - Stocks·2y ago
News Placeholder
Corbus Pharmaceuticals Holdings (CRBP, $44.79) RSI Indicator left the overbought zone on March 14, 2024
This is a signal that CRBP's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
Tickeron - Stocks·2y ago

Latest CRBP News

View

Advertisement|Remove ads.

Advertisement|Remove ads.